Literature DB >> 28705619

Patient acceptability, safety and access: A balancing act for selecting age-appropriate oral dosage forms for paediatric and geriatric populations.

Jennifer Walsh1, Sejal R Ranmal2, Terry B Ernest3, Fang Liu4.   

Abstract

The selection and design of age-appropriate formulations intended for use in paediatric and geriatric patients are dependent on multiple factors affecting patient acceptability, safety and access. The development of an economic and effective product relies on a balanced consideration of the risks and benefits of these factors. This review provides a comprehensive and up-to-date analysis of oral dosage forms considering key aspects of formulation design including dosage considerations, ease of use, tolerability and safety, manufacturing complexity, stability, supply and cost. Patient acceptability has been examined utilising an evidence-based approach to evaluate regulatory guidance and literature. Safety considerations including excipients and potential risk of administration errors of the different dosage forms are also discussed, together with possible manufacturing and supply challenges. Age appropriate drug product design should consider and compare i) acceptability ii) safety and iii) access, although it is important to recognise that these factors must be balanced against each other, and in some situations a compromise may need to be reached when selecting an age-appropriate formulation.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Acceptability; Access; Drug product design; Formulation; Geriatric; Manufacture; Oral; Pediatric

Mesh:

Substances:

Year:  2017        PMID: 28705619     DOI: 10.1016/j.ijpharm.2017.07.017

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  12 in total

1.  Development and evaluation of an assessment of the age-appropriateness/inappropriateness of formulations used in children.

Authors:  Jennifer C Duncan; Louise E Bracken; Anthony J Nunn; Matthew Peak; Mark A Turner
Journal:  Int J Clin Pharm       Date:  2022-10-08

2.  A chewable pediatric preparation of ibuprofen is palatable and acceptable to children.

Authors:  Steven Barnett; Aomesh Bhatt
Journal:  Paediatr Neonatal Pain       Date:  2020-02-10

3.  Epinephrine in Anaphylaxis: Preclinical Study of Pharmacokinetics after Sublingual Administration of Taste-Masked Tablets for Potential Pediatric Use.

Authors:  Ousama Rachid; Mutasem Rawas-Qalaji; Keith J Simons
Journal:  Pharmaceutics       Date:  2018-02-11       Impact factor: 6.321

4.  Self-microemulsifying oral fast dissolving films of vitamin D3 for infants: Preparation and characterization.

Authors:  Min Zhang; Tingrui Zhang; Ying Zou; Ping Han; Kehai Liu
Journal:  Food Sci Nutr       Date:  2019-07-11       Impact factor: 2.863

5.  Dosage form suitability in vulnerable populations: A focus on paracetamol acceptability from infants to centenarians.

Authors:  Fabrice Ruiz; Thibault Vallet; Amélie Dufaÿ Wojcicki; Émilie Belissa; Jean-Eudes Fontan; Loïc de Pontual; Sylvie Nathanson; Alain Chevallier; Sandra Laribe-Caget; Vincent Boudy
Journal:  PLoS One       Date:  2019-08-20       Impact factor: 3.240

6.  Acceptability of oral liquid pharmaceutical products in older adults: palatability and swallowability issues.

Authors:  Emilie Belissa; Thibault Vallet; Sandra Laribe-Caget; Alain Chevallier; François-Xavier Chedhomme; Fattima Abdallah; Nathalie Bachalat; Sid-Ahmed Belbachir; Imad Boulaich; Vanessa Bloch; Anne Delahaye; Mathieu Depoisson; Amélie Dufaÿ Wojcicki; Stéphane Gibaud; Anne-Sophie Grancher; Caroline Guinot; Celia Lachuer; Laurent Lechowski; Patrick Leglise; Abdel Mahiou; Sylvie Meaume; Corinne Michel; Hugues Michelon; Yann Orven; Ines Perquy; Matthieu Piccoli; Maïté Rabus; Annie-Claude Ribemont; Jean-Paul Rwabihama; Jean-Hugues Trouvin; Fabrice Ruiz; Vincent Boudy
Journal:  BMC Geriatr       Date:  2019-12-07       Impact factor: 3.921

Review 7.  Innovations in Pediatric Drug Formulations and Administration Technologies for Low Resource Settings.

Authors:  Stephen E Gerrard; Jennifer Walsh; Niya Bowers; Smita Salunke; Susan Hershenson
Journal:  Pharmaceutics       Date:  2019-10-08       Impact factor: 6.321

8.  Children's Preferences for Oral Dosage Forms and Their Involvement in Formulation Research via EPTRI (European Paediatric Translational Research Infrastructure).

Authors:  Elisa Alessandrini; Francis Brako; Mariagiovanna Scarpa; Mariangela Lupo; Donato Bonifazi; Valeria Pignataro; Maria Cavallo; Ornela Cullufe; Cristina Enache; Begonya Nafria; Joana Claverol; Leen De Taeye; Eric Vermeulen; Jennifer Preston; Catherine Tuleu
Journal:  Pharmaceutics       Date:  2021-05-15       Impact factor: 6.321

Review 9.  Patient Centric Pharmaceutical Drug Product Design-The Impact on Medication Adherence.

Authors:  Enrica Menditto; Valentina Orlando; Giuseppe De Rosa; Paola Minghetti; Umberto Maria Musazzi; Caitriona Cahir; Marta Kurczewska-Michalak; Przemysław Kardas; Elísio Costa; José Manuel Sousa Lobo; Isabel F Almeida
Journal:  Pharmaceutics       Date:  2020-01-03       Impact factor: 6.321

10.  Availability of age-appropriate paediatric formulations in the Netherlands: the need in daily clinical practice remains.

Authors:  Anna van der Vossen; Sandra Buljaç; Kadir Akçay; Jan Dietert Brugma; Arnold Vulto; Lidwien Hanff
Journal:  Eur J Hosp Pharm       Date:  2019-11-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.